Novavax announces closing of public offering
Novavax announced the closing of the underwritten public offering priced on March 25, 2015. The company issued 27,758,620 shares of its common stock, including 3,620,689 shares pursuant to the underwriters' option to purchase additional shares. Gross proceeds were $201,250,000. March 31, 2015